Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I

被引:246
作者
Rye, KA [1 ]
Barter, PJ [1 ]
机构
[1] Heart Res Inst, Sydney, NSW 2050, Australia
关键词
apoA-I; prebeta HDL; CETP; HDL remodeling; PLTP;
D O I
10.1161/01.ATV.0000104029.74961.f5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The preferred extracellular acceptor of cell phospholipids and unesterified cholesterol in the process mediated by the ATP-binding cassette A1 (ABCA1) transporter is a monomolecular, prebeta-migrating, lipid-poor or lipid-free form of apolipoprotein (apo) A-I. This monomolecular form of apoA-I is quite distinct from the prebeta-migrating, discoidal high-density lipoprotein (HDL) that contains two or three molecules of apoA-I per particle and which are present as minor components of the HDL fraction in human plasma. The mechanism of the ABCA1-mediated efflux of phospholipid and cholesterol from cells has been studied extensively. In contrast, much less attention has been given to the origin and subsequent metabolism of the acceptor lipid-free/lipid-poor apoA-I. There is a substantial body of evidence from studies conducted in vitro that a monomolecular, lipid-free/lipid-poor form of apoA-I dissociates from HDL during the remodeling of HDLs by plasma factors such as cholesteryl ester transfer protein, hepatic lipase, and phospholipid transfer protein. The rate at which apoA-I dissociates from HDL is influenced by the phospholipid composition of the particles and by the presence of apoA-II. This review describes current knowledge regarding the formation, metabolism, and regulation of monomolecular, lipid-free/lipid-poor apoA-I in plasma.
引用
收藏
页码:421 / 428
页数:8
相关论文
共 71 条
[1]   Role of free apolipoprotein A-I in cholesterol efflux - Formation of pre-alpha-migrating high-density lipoprotein particles [J].
Asztalos, B ;
Zhang, WW ;
Roheim, PS ;
Wong, L .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (09) :1630-1636
[2]   2-DIMENSIONAL ELECTROPHORESIS OF PLASMA-LIPOPROTEINS - RECOGNITION OF NEW APO-A-I-CONTAINING SUBPOPULATIONS [J].
ASZTALOS, BF ;
SLOOP, CH ;
WONG, L ;
ROHEIM, PS .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1169 (03) :291-300
[3]   Pre-beta HDL: Structure and metabolism [J].
Barrans, A ;
Jaspard, B ;
Barbaras, R ;
Chap, H ;
Ferret, B ;
Collet, X .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1300 (02) :73-85
[4]  
BARRANS A, 1994, J BIOL CHEM, V269, P11572
[5]   High density lipoproteins and coronary heart disease [J].
Barter, PJ ;
Rye, KA .
ATHEROSCLEROSIS, 1996, 121 (01) :1-12
[6]   Enhancing medication adherence among inner-city children with asthma: Results from pilot studies [J].
Bartlett, SJ ;
Lukk, P ;
Butz, A ;
Lampros-Klein, F ;
Rand, CS .
JOURNAL OF ASTHMA, 2002, 39 (01) :47-54
[7]   CHARACTERIZATION OF HUMAN HIGH-DENSITY LIPOPROTEINS BY GRADIENT GEL-ELECTROPHORESIS [J].
BLANCHE, PJ ;
GONG, EL ;
FORTE, TM ;
NICHOLS, AV .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 665 (03) :408-419
[8]  
BORRESEN AL, 1980, ARTERY, V7, P139
[9]   Human apolipoprotein A-II inhibits the formation of pre-beta high density lipoproteins [J].
Calabresi, L ;
Lucchini, A ;
Vecchio, G ;
Sirtori, CR ;
Franceschini, G .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1304 (01) :32-42
[10]   EARLY INCORPORATION OF CELL-DERIVED CHOLESTEROL INTO PRE-BETA-MIGRATING HIGH-DENSITY LIPOPROTEIN [J].
CASTRO, GR ;
FIELDING, CJ .
BIOCHEMISTRY, 1988, 27 (01) :25-29